Fabagal®
Description
A drug for therapy of the orphan Fabry disease.
Application
For long-term enzyme replacement therapy of patients with confirmed diagnosis of Fabry disease (a rare genetically determined disease, causing kidney problems, neuropathic limb pain, congestive heart failure and stroke).
Active ingredients
Agalsidase beta.